Haemophilus Type B Conjugate Vaccine IP

Product Description

The Haemophilus Type B Conjugate Vaccine IP is a vaccine used to protect against Haemophilus influenzae type b infections. Haemophilus influenzae is a bacterium that can cause severe illnesses, particularly in young children. The Hib conjugate vaccine is designed to stimulate the body's immune system to produce antibodies against the Haemophilus influenzae type b bacteria.  This conjugation enhances the immune response, particularly in young children whose immune systems are still developing. Haemophilus Type B Conjugate Vaccine IP is typically given to infants and young children as part of routine childhood immunization schedules. It is often administered as a series of doses, with the primary series usually given at 2, 4, and 6 months of age.

Form - Liquid